REPORT ID 3262

Global Peripheral Arterial Disease (PAD) Therapeutics Market ResearchReport 2019

Publish Date
2019
Pages
112
Format
Electronic (PDF)

In this report, the global Peripheral Arterial Disease (PAD) Therapeutics market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Peripheral Arterial Disease (PAD) Therapeutics in these regions, from   2019 to 2025 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Peripheral Arterial Disease (PAD) Therapeutics market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    AstraZeneca Plc. (UK)
    Bayer HealthCare Pharmaceuticals (Germany)
    Bristol-Myers Squibb Company (US)
    Merck & Co., Inc. (US)
    Proteon Therapeutics, Inc. (US)
    Sanofi S.A. (France)
    Symic Bio, Inc. (US)
    TheraVasc Inc. (US)
    AnGes MG, Inc. (Japan)
    Athersys, Inc. (US)
    Betagenon AB (Sweden)
    miRagen Therapeutics, Inc. (US)
    Multi Gene Vascular Systems Ltd (Israel)
    ViroMed Co. Ltd. (Korea)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Anti-Platelet Drugs
    Dual Antiplatelet Therapy Drugs
    Others
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Hospitals
    Clinics
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Peripheral Arterial Disease (PAD) Therapeutics Market Research  Report 2019
1 Peripheral Arterial Disease (PAD) Therapeutics Market Overview
    1.1 Product Overview and Scope of Peripheral Arterial Disease (PAD) Therapeutics
    1.2 Peripheral Arterial Disease (PAD) Therapeutics Segment by Type (Product Category)
        1.2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Production and CAGR (%) Comparison by Type (Product Category)( 2014-2024)
        1.2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Production Market Share by Type (Product Category)  in 2018
        1.2.3 Anti-Platelet Drugs
        1.2.4 Dual Antiplatelet Therapy Drugs
        1.2.5 Others
    1.3 Global Peripheral Arterial Disease (PAD) Therapeutics Segment by Application
        1.3.1 Peripheral Arterial Disease (PAD) Therapeutics Consumption (Sales) Comparison by Application ( 2014-2024)
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Global Peripheral Arterial Disease (PAD) Therapeutics Market by Region ( 2014-2024)
        1.4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Market Size (Value) and CAGR (%) Comparison by Region ( 2014-2024)
        1.4.2 North America Status and Prospect ( 2014-2024)
        1.4.3 Europe Status and Prospect ( 2014-2024)
        1.4.4 China Status and Prospect ( 2014-2024)
        1.4.5 Japan Status and Prospect ( 2014-2024)
        1.4.6 Southeast Asia Status and Prospect ( 2014-2024)
        1.4.7 India Status and Prospect ( 2014-2024)
    1.5 Global Market Size (Value) of Peripheral Arterial Disease (PAD) Therapeutics ( 2014-2024)
        1.5.1 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue Status and Outlook ( 2014-2024)
        1.5.2 Global Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production Status and Outlook ( 2014-2024)

2 Global Peripheral Arterial Disease (PAD) Therapeutics Market Competition by Manufacturers
    2.1 Global Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production and Share by Manufacturers ( 2014-2019)
        2.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Capacity and Share by Manufacturers ( 2014-2019)
        2.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Production and Share by Manufacturers ( 2014-2019)
    2.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue and Share by Manufacturers ( 2014-2019)
    2.3 Global Peripheral Arterial Disease (PAD) Therapeutics Average Price by Manufacturers ( 2014-2019)
    2.4 Manufacturers Peripheral Arterial Disease (PAD) Therapeutics Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Peripheral Arterial Disease (PAD) Therapeutics Market Competitive Situation and Trends
        2.5.1 Peripheral Arterial Disease (PAD) Therapeutics Market Concentration Rate
        2.5.2 Peripheral Arterial Disease (PAD) Therapeutics Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue (Value) by Region ( 2014-2019)
    3.1 Global Peripheral Arterial Disease (PAD) Therapeutics Capacity and Market Share by Region ( 2014-2019)
    3.2 Global Peripheral Arterial Disease (PAD) Therapeutics Production and Market Share by Region ( 2014-2019)
    3.3 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue (Value) and Market Share by Region ( 2014-2019)
    3.4 Global Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.5 North America Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.6 Europe Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.7 China Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.8 Japan Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.9 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
    3.10 India Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)

4 Global Peripheral Arterial Disease (PAD) Therapeutics Supply (Production), Consumption, Export, Import by Region ( 2014-2019)
    4.1 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption by Region ( 2014-2019)
    4.2 North America Peripheral Arterial Disease (PAD) Therapeutics Production, Consumption, Export, Import ( 2014-2019)
    4.3 Europe Peripheral Arterial Disease (PAD) Therapeutics Production, Consumption, Export, Import ( 2014-2019)
    4.4 China Peripheral Arterial Disease (PAD) Therapeutics Production, Consumption, Export, Import ( 2014-2019)
    4.5 Japan Peripheral Arterial Disease (PAD) Therapeutics Production, Consumption, Export, Import ( 2014-2019)
    4.6 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Production, Consumption, Export, Import ( 2014-2019)
    4.7 India Peripheral Arterial Disease (PAD) Therapeutics Production, Consumption, Export, Import ( 2014-2019)

5 Global Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue (Value), Price Trend by Type
    5.1 Global Peripheral Arterial Disease (PAD) Therapeutics Production and Market Share by Type ( 2014-2019)
    5.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue and Market Share by Type ( 2014-2019)
    5.3 Global Peripheral Arterial Disease (PAD) Therapeutics Price by Type ( 2014-2019)
    5.4 Global Peripheral Arterial Disease (PAD) Therapeutics Production Growth by Type ( 2014-2019)

6 Global Peripheral Arterial Disease (PAD) Therapeutics Market Analysis by Application
    6.1 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption and Market Share by Application ( 2014-2019)
    6.2 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption Growth Rate by Application ( 2014-2019)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Peripheral Arterial Disease (PAD) Therapeutics Manufacturers Profiles/Analysis
    7.1 AstraZeneca Plc. (UK)
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 AstraZeneca Plc. (UK) Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.1.4 Main Business/Business Overview
    7.2 Bayer HealthCare Pharmaceuticals (Germany)
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 Bayer HealthCare Pharmaceuticals (Germany) Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.2.4 Main Business/Business Overview
    7.3 Bristol-Myers Squibb Company (US)
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Bristol-Myers Squibb Company (US) Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.3.4 Main Business/Business Overview
    7.4 Merck & Co., Inc. (US)
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Merck & Co., Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.4.4 Main Business/Business Overview
    7.5 Proteon Therapeutics, Inc. (US)
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Proteon Therapeutics, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.5.4 Main Business/Business Overview
    7.6 Sanofi S.A. (France)
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Sanofi S.A. (France) Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.6.4 Main Business/Business Overview
    7.7 Symic Bio, Inc. (US)
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 Symic Bio, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.7.4 Main Business/Business Overview
    7.8 TheraVasc Inc. (US)
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 TheraVasc Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.8.4 Main Business/Business Overview
    7.9 AnGes MG, Inc. (Japan)
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 AnGes MG, Inc. (Japan) Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.9.4 Main Business/Business Overview
    7.10 Athersys, Inc. (US)
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Peripheral Arterial Disease (PAD) Therapeutics Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Athersys, Inc. (US) Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue, Price and Gross Margin ( 2014-2019)
        7.10.4 Main Business/Business Overview
    7.11 Betagenon AB (Sweden)
    7.12 miRagen Therapeutics, Inc. (US)
    7.13 Multi Gene Vascular Systems Ltd (Israel)
    7.14 ViroMed Co. Ltd. (Korea)

8 Peripheral Arterial Disease (PAD) Therapeutics Manufacturing Cost Analysis
    8.1 Peripheral Arterial Disease (PAD) Therapeutics Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Peripheral Arterial Disease (PAD) Therapeutics

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Peripheral Arterial Disease (PAD) Therapeutics Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Peripheral Arterial Disease (PAD) Therapeutics Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Peripheral Arterial Disease (PAD) Therapeutics Market Forecast ( 2019-2025)
    12.1 Global Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production, Revenue Forecast ( 2019-2025)
        12.1.1 Global Peripheral Arterial Disease (PAD) Therapeutics Capacity, Production and Growth Rate Forecast ( 2019-2025)
        12.1.2 Global Peripheral Arterial Disease (PAD) Therapeutics Revenue and Growth Rate Forecast ( 2019-2025)
        12.1.3 Global Peripheral Arterial Disease (PAD) Therapeutics Price and Trend Forecast ( 2019-2025)
    12.2 Global Peripheral Arterial Disease (PAD) Therapeutics Production, Consumption , Import and Export Forecast by Region ( 2019-2025)
        12.2.1 North America Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.2 Europe Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.3 China Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.4 Japan Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.5 Southeast Asia Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
        12.2.6 India Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue, Consumption, Export and Import Forecast ( 2019-2025)
    12.3 Global Peripheral Arterial Disease (PAD) Therapeutics Production, Revenue and Price Forecast by Type ( 2019-2025)
    12.4 Global Peripheral Arterial Disease (PAD) Therapeutics Consumption Forecast by Application ( 2019-2025)

13 Research Findings and Conclusion

14 A